Safety and Pharmacokinetics Study of SyB L-1101 in Patients With Recurrent/Relapsed or Refractory Myelodysplastic Syndrome (MDS)
Clinical trial NCT01700335 · COMPLETED
Trial details
- NCT number
- NCT01700335
- Sponsor
- SymBio Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2015-02-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.